Victrelis and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victrelis (boceprevir) and Furosemide (furosemide). Common drug interactions include generalised oedema among females and ascites among males.

The phase IV clinical study analyzes what interactions people have when they take Victrelis and Furosemide. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Victrelis?

Victrelis has active ingredients of boceprevir. It is often used in hepatitis c. eHealthMe is studying from 8,634 Victrelis users. Check the latest studies of Victrelis.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

On Jul, 05, 2026

68 people who take Victrelis and Furosemide together, and have interactions are studied.

Victrelis and Furosemide drug interactions.

What are the common drug interactions of Victrelis and Furosemide, by gender? *:

female:

Generalised oedema (swelling all over the body)
Influenza like illness
Oedema peripheral (superficial swelling)
Platelet count decreased
Pyrexia (fever)
Rash
Skin warm
Vasculitis (inflammation of a blood vessel or blood vessels)
Ankle fracture
Balance disorder

male:

Ascites (accumulation of fluid in the abdominal cavity)
Splenomegaly (enlargement of spleen)
Abdominal pain
Chest pain
Decreased appetite
Haemoglobin decreased
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Influenza like illness
Insomnia (sleeplessness)
Joint swelling

What are the common drug interactions of Victrelis and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Blood glucose increased
Confusional state
Injection site pain
Ketoacidosis (high concentrations of ketone bodies in blood)
Loss of consciousness
Multi-organ failure (multisystem organ failure)
Platelet count decreased

30-39:

n/a

40-49:

Adverse event
Influenza
Pleural effusion (water on the lungs)
Pneumonia
Dysgeusia (disorder of the sense of taste)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Wound infection

50-59:

Pyrexia (fever)
Rash
Rebound effect (take-back effect)
Red blood cell count decreased
Renal failure acute (rapid kidney dysfunction)
Sensation of heaviness
Syncope (loss of consciousness with an inability to maintain postural tone)
Thrombocytopenia (decrease of platelets in blood)
Tinnitus (a ringing in the ears)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)

60+:

Anaemia (lack of blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Vasculitis (inflammation of a blood vessel or blood vessels)
Alanine aminotransferase increased
Antidiuretic hormone abnormality
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Bladder dysfunction

What are the existing conditions these people have? *

Anaemia (lack of blood): 6 people, 8.82%
Oedema Peripheral (superficial swelling): 5 people, 7.35%
Diabetes: 5 people, 7.35%
Cardiac Failure: 4 people, 5.88%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 5.88%
Abdominal Pain Upper: 4 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Victrelis and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously